Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Greenmerc | GMERCB | Nov 22, 2024 | 6.56 | -9.89 |
Gruvaktiebolaget Viscaria | VISC | Nov 22, 2024 | 22.10 | +1.61 |
Gränges | GRNG | Nov 22, 2024 | 117.80 | -0.51 |
Grängesberg Exploration Holding | GRANGX | Nov 22, 2024 | 9.00 | +2.62 |
Guard Therapeutics International | GUARD | Nov 22, 2024 | 20.60 | +1.98 |
Guideline Geo | GGEO | Nov 22, 2024 | 7.94 | +1.28 |
Gullberg & Jansson | GJAB | Nov 22, 2024 | 15.35 | +0.33 |
H&D Wireless Sweden Holding B | HDWB | Nov 22, 2024 | 0.00 | 0.00 |
H&M B | HMB | Nov 22, 2024 | 155.40 | +1.20 |
HAKI Safety A | HAKIA | Nov 22, 2024 | 27.00 | 0.00 |
HAKI Safety B | HAKIB | Nov 22, 2024 | 25.40 | 0.00 |
Hamlet BioPharma AB (publ) | HAMLETB | Nov 22, 2024 | 2.62 | -2.24 |
Hansa Biopharma | HNSA | Nov 22, 2024 | 30.68 | +2.68 |
Hanza AB | HANZA | Nov 22, 2024 | 68.05 | +3.81 |
Harm Reduction Group | NOHARM | Nov 22, 2024 | 0.05 | +0.38 |
Havsfrun Investment | HAVS | Nov 22, 2024 | 13.70 | +4.58 |
Havsfrun Investment B | HAVB | Nov 22, 2024 | 13.70 | +4.58 |
Haypp Group | HAYPP | Nov 22, 2024 | 61.20 | +2.34 |
Headsent | VIMAB | Nov 22, 2024 | 7.50 | -3.23 |
Heba B | HEBAB | Nov 22, 2024 | 31.30 | +2.29 |
Hedera Group | HEGR | Nov 22, 2024 | 2.42 | -3.20 |
Heimstaden Pref | HEIMPREF | Nov 22, 2024 | 14.04 | -2.90 |
Heliospectra | HELIO | Nov 22, 2024 | 0.49 | -1.01 |
Hemnet Group | HEM | Nov 22, 2024 | 325.80 | +1.50 |
Hemply Balance | HMPLY | Nov 22, 2024 | 0.04 | +11.11 |
Hernö Gin B | HERNOB | Nov 22, 2024 | 3.85 | -1.41 |
Hexagon B | HEXAB | Nov 22, 2024 | 91.86 | +0.81 |
Hexagon Purus | HPURO | Nov 22, 2024 | 4.92 | 0.00 |
Hexatronic Group | HTRO | Nov 22, 2024 | 37.00 | +1.51 |
Hexicon | HEXI | Nov 22, 2024 | 0.17 | +4.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.